Owen Collins

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome

Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors

Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies

The Etiology of Community‐Acquired Pneumonia in Australia: Why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections

Cholinesterase Inhibitors Stabilize Alzheimer Disease

A Randomized Study of Sequential Intravenous/Oral Moxifloxacin in Comparison to Sequential Intravenous Ceftriaxone/Oral Cefuroxime Axetil in Patients with Hospital-Acquired Pneumonia

Acetylcholinesterase Inhibitors: Pharmacology and Toxicology

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs

Moxifloxacin

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

Guidelines for the management of adult lower respiratory tract infections

Assessment and management of behavioral and psychological symptoms of dementia

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

Position Paper: Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Community‐Acquired Pneumonia

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study

Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.

The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease

Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults

Cholinesterase inhibitors for Alzheimer's disease

A multicentre, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild‐to‐moderate Alzheimer's disease: the MALT study

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment